首页> 美国卫生研究院文献>other >PWZ-029 A COMPOUND WITH MODERATE INVERSE AGONIST FUNCTIONAL SELECTIVITY AT GABAA RECEPTORS CONTAINING α5 SUBUNITS IMPROVES PASSIVE BUT NOT ACTIVE AVOIDANCE LEARNING IN RATS
【2h】

PWZ-029 A COMPOUND WITH MODERATE INVERSE AGONIST FUNCTIONAL SELECTIVITY AT GABAA RECEPTORS CONTAINING α5 SUBUNITS IMPROVES PASSIVE BUT NOT ACTIVE AVOIDANCE LEARNING IN RATS

机译:PWZ-029在包含α5亚基的GABAA受体上具有中等程度逆向激动剂功能选择性的化合物可改善被动但不活跃大鼠的逃避学习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Benzodiazepine (BZ) site ligands affect vigilance, anxiety, memory processes, muscle tone and epileptogenic propensity through modulation of neurotransmission at GABAA receptors containing α1, α2, α3 or α5 subunits, and may have numerous experimental and clinical applications. The ability of nonselective BZ site inverse agonists to enhance cognition, documented in animal models and human studies, is clinically not feasible due to potentially unacceptable psychomotor effects. Most investigations to date have proposed the α1 and/or α5 subunit-containing GABAA receptors as comprising the memory-modulating population of these receptors. The novel ligand PWZ-029, which we synthesised and characterized electrophysiologically, possesses in vitro binding selectivity and moderate inverse agonist functional selectivity at α5-containing GABAA receptors. This ligand has also been examined in rats in the passive and active avoidance, spontaneous locomotor activity, elevated plus maze and grip strength tests, primarily predictive of the effects on the memory acquisition, basal locomotor activity, anxiety level and muscle tone, respectively. The improvement of task learning was detected at the dose of 5 mg/kg in the passive, but not active avoidance test. The inverse agonist PWZ-029 had no effect on anxiety or muscle tone, whereas at higher doses (10 and 20 mg/kg) it decreased locomotor activity. This effect was antagonized by flumazenil and also by the lower (but not the higher) dose of an agonist (SH-053-R-CH3-2’F) selective for GABAA receptors containing the α5 subunit. The hypolocomotor effect of PWZ-029 was not antagonized by the antagonist β-CCt exhibiting a preferential affinity for α1-subunit containing receptors. These data suggest that moderate negative modulation at GABAA receptors containing the α5 subunit is a sufficient condition for eliciting enhanced encoding/consolidation of declarative memory, while the influence of higher doses of modulators at these receptors on motor activity shows an intricate pattern whose relevance and mechanism await to be defined.
机译:苯二氮卓(BZ)位点配体通过调节包含α1,α2,α3或α5亚基的GABAA受体的神经传递来影响警惕性,焦虑,记忆过程,肌肉张力和癫痫发生倾向,并且可能具有许多实验和临床应用。在动物模型和人体研究中记录的非选择性BZ位点反向激动剂增强认知的能力在临床上是不可行的,因为其潜在的精神运动效应可能无法接受。迄今为止,大多数研究已提出含α1和/或α5亚基的GABAA受体包含这些受体的记忆调节种群。我们通过电生理学合成和表征了新型配体PWZ-029,它对含α5的GABAA受体具有体外结合选择性和中等的反向激动剂功能选择性。还已经在大鼠的被动和主动回避,自发运动能力,增强的迷宫和抓地力测试中检查了该配体,主要预测了对记忆获得,基础运动能力,焦虑水平和肌张力的影响。在被动(而非主动)回避测试中,以5 mg / kg的剂量发现了任务学习的改善。反向激动剂PWZ-029对焦虑或肌肉张力没有影响,而在较高剂量(10和20 mg / kg)下,它会降低运动能力。氟马西尼和较低(但不是较高)剂量的对含有α5亚基的GABAA受体具有选择性的激动剂(SH-053-R-CH3-2’F)都可拮抗这一作用。 PWZ-029的低速运动作用并未被拮抗剂β-CCt拮抗,后者对含α1亚基的受体表现出优先亲和力。这些数据表明,在含有α5亚基的GABAA受体上适度的负调节是引发声明性记忆增强编码/巩固的充分条件,而在这些受体上更高剂量的调节剂对运动活性的影响显示出其相关性和机理的复杂模式等待定义。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号